Although not statistically different than CD133− cell populations (p = 0.29), the tumor-initiating potential of cells enriched for CD133 is well documented in multiple studies from malignancies from various organ systems, including pancreatic cancer. The gene discussed is PROM1; the disease is neoplasm.